Intrinsic Value of S&P & Nasdaq Contact Us

Beam Therapeutics Inc. BEAM

NASDAQ Global Select

SharesGrow Score
53/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$40.86
+34.9%

Beam Therapeutics Inc. (BEAM) current share price is $30.30. The gold spot price is $4,808.10 per troy ounce. Using the formula: BEAM in gold = $30.30 × 31.1035 ÷ $4,808.10 = 0.1960 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of BEAM when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding BEAM shares over the measured period.

BEAM in US Dollars
Gold in US Dollars
BEAM in Gold (grams per share)

Real Wealth Growth Rate

BEAM
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{BEAM}_{\text{gold}}(t) = \frac{P_{\text{BEAM}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{BEAM}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{BEAM}_{\text{gold}}^{(T)}}{\text{BEAM}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{BEAM}_\text{gold}^{(0)}$ = initial gold-price, $\text{BEAM}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

VRTX
VRTX
Vertex Pharmaceuticals Incorporated
$444.28
+0.96%
CRSP
CRSP
CRISPR Therapeutics AG
$56.86
+3.70%
NTLA
NTLA
Intellia Therapeutics, Inc.
$14.78
+3.65%
VERV
VERV
Verve Therapeutics, Inc.
$11.13
+0.27%
SANA
SANA
Sana Biotechnology, Inc.
$3.48
+8.41%
PRME
PRME
Prime Medicine, Inc.
$3.70
+1.09%
DNA
DNA
Ginkgo Bioworks Holdings, Inc.
$7.72
+15.57%
EDIT
EDIT
Editas Medicine, Inc.
$3.39
+5.94%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message